Page 596 - Clinical Hematology_ Theory _ Procedures ( PDFDrive )

580 PART 7 ■ Principles and Disorders of Hemostasis and Thrombosis

CASE STUDIES (continued)
CASE STUDIES (continued)

9
■ Critical Thinking Group Discussion Questions P ate et count 75 × 10 /L
1. What is the iagnosis in this case? B ee ing ti e 10 inutes

AP 65 secon s (contro , 29 secon s)

2. Can this atient sa e y un ergo surgery? P 19 secon s (contro , 11 secon s)

T ro bin ti e 24 secon s (nor a , 18 to 22 secon s)

3. What is the ro e o the aboratory in a surgica case o Fibrinogen 90 g/ L (nor a , 200 to 400 g/ L)

this ty e? FSP screen ositive

Prota ine su ate test ositive

Case Study 28.4 ■ Critical Thinking Group Discussion Questions

1. What is the ost robab e cause o the extensive b ee -
A wo an was a itte in abor to the obstetrica unit at ing in this case?
11 pm. Her history an hysica exa ination revea e no

signi cant abnor a ities. At the ti e o a ission, she 2. What is the etio ogy o this isor er?
was having irregu ar contractions.

In the e ivery roo , b ee ing beca e extensive. A S A 3. Wi the trans usion o who e or resh b oo re ress the

he og obin, he atocrit, ty e an cross atch or our b ee ing?

units o b oo , an coagu ation ro e were or ere .

■ Laboratory Data
He og obin 10.0 g/L NOTE: This is a good time to write out the answers to the

He atocrit 27% Critical Thinking Group Discussion Questions.

REVIEW QUESTIONS

*Indicates ML (optional) and MLS advanced content. *4. Unique characteristic associate with a e ciency o

actor XII e ciency is

Disorders o De ective Production A. requent noseb ee s

1. Which o the o owing ara eters can be abnor a in B. no history o b ee ing

c assic von Wi ebran ’s isease ty e I? C. a co on actor e ciency
A. B ee ing ti e D. ecrease risk o or ing b oo c ots

B. P
C. P ate et count Disorders o Destruction and Consumption

D. A o the above *5. Disse inate intravascu ar coagu ation (DIC) can be
initiate by

*2. P ate et aggregation stu ies in cases o c assic von A. se tic shock
Wi ebran ’s isease shou revea B. severe se sis

A. nor a ate et aggregation when actors such as C. he o ytic RBC crisis
ristocetin are use or testing D. a o the above

B. absence o aggregation when actors such as
e ine hrine are use or testing *6. Laboratory resu ts in acute DIC ref ect abnor a ities in

C. ecrease aggregation when actors such as ristoce- which o the o owing coagu ation co onents?
tin are use or testing A. P ate et unction

D. ecrease ADP activity when teste B. Excessive c otting an brino ysis
C. Acce erate thro bin or ation

*3. he ost co on or o von Wi ebran ’s D. Fibrin or ation
isease is *7. Pri ary brino ysis is characterize by

A. ty e I A. gross activation o the brino ytic echanis
B. ty e II B. consu tion o brinogen

C. ty e III C. consu tion o coagu ation actors
D. a have about the sa e inci ence D. a o the above